Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial
LaGuardia, K.D.
Obstetrics and Gynecology 123(5): 1107-1108
2014
ISSN/ISBN: 1873-233X PMID: 24785869 DOI: 10.1097/aog.0000000000000247Document Number: 578840
Document emailed within 0-6 h
Related Documents
LaGuardia, K.D. 2014: Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial Obstetrics and Gynecology 123(5): 1107-1108LaGuardia, K.D. 2014: Low-dose levonorgestrel and ethinyl estradiol patch and pill: a randomized controlled trial Obstetrics and Gynecology 123(5): 1107-1108
Krishnan, S.; Kiley, J. 2010: The lowest-dose, extended-cycle combined oral contraceptive pill with continuous ethinyl estradiol in the United States: a review of the literature on ethinyl estradiol 20 μg/levonorgestrel 100 μg + ethinyl estradiol 10 μg International Journal of Women's Health 2: 235-239
Kaunitz, A.; Archer, D.; Foegh, M. 2012: Safety and tolerability of the agile patch, a contraceptive patch with low-dose ethinyl estradiol (EE) and levonorgestrel (LNG), vs. combination oral contraceptives (COCs) in obese vs. non-obese women Fertility and Sterility 98(3): S195-S196
Creinin, M.D.; Lippman, J.S.; Eder, S.E.; Godwin, A.J.; Olson, W. 2002: The effect of extending the pill-free interval on follicular activity: triphasic norgestimate/35 micro g ethinyl estradiol versus monophasic levonorgestrel/20 micro g ethinyl estradiol Contraception 66(3): 147-152
DelConte, A.; Loffer, F.; Grubb, G.S. 1999: Cycle control with oral contraceptives containing 20 micrograms of ethinyl estradiol. a multicenter, randomized comparison of levonorgestrel/ethinyl estradiol (100 micrograms/20 micrograms) and norethindrone/ethinyl estradiol (1000 micrograms/20 micrograms) Contraception 59(3): 187-193
Kashanian, M.; Shahpourian, F.; Zare, O. 2010: A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran European Journal of Obstetrics Gynecology and Reproductive Biology 150(1): 47-51
Oner, G.; Muderris, I.I. 2011: A prospective randomized trial comparing low-dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirsutism Contraception 84(5): 508-511
Madden, T.; Proehl, S.; Allsworth, J.E.; Secura, G.M.; Peipert, J.F. 2012: Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial American Journal of Obstetrics and Gynecology 206(2): 129.E1-8
Maloney, J.M.; Dietze, P.; Watson, D.; Niknian, M.; Lee-Rugh, S.; Sampson-Landers, C.; Korner, P. 2008: Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial Obstetrics and Gynecology 112(4): 773-781
Nelson, A.; Apter, D.; Hauck, B.; Schmelter, T.; Rybowski, S.; Rosen, K.; Gemzell-Danielsson, K. 2013: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstetrics and Gynecology 122(6): 1205-1213
Nelson, A.; Apter, D.; Hauck, B.; Schmelter, T.; Rybowski, S.; Rosen, K.; Gemzell-Danielsson, K. 2013: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Obstetrics and Gynecology 122(6): 1205-1213
Bahamondes, L. 2014: Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial Reference 123(3): 667
Archer, D.F.; Maheux, R.; DelConte, A.; O'Brien, F.B. 1999: Efficacy and safety of a low-dose monophasic combination oral contraceptive containing 100 microg levonorgestrel and 20 microg ethinyl estradiol (Alesse). North american Levonorgestrel Study Group (NALSG) American Journal of Obstetrics and Gynecology 181(5 Pt 2): 39-44
Lepot, M.R.; Gaspard, U.J. 1987: Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene International Journal of Fertility 32 Suppl: 15-20
Harada, T.; Momoeda, M.; Terakawa, N.; Taketani, Y.; Hoshiai, H. 2011: Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial Fertility and Sterility 95(6): 1928-1931
Portman, D.J.; Kaunitz, A.M.; Howard, B.; Weiss, H.; Hsieh, J.; Ricciotti, N. 2014: Efficacy and safety of an ascending-dose, extended-regimen levonorgestrel/ethinyl estradiol combined oral contraceptive Contraception 89(4): 299-306
Höchel, J.; Schuett, B.; Ludwig, M.; Zurth, C. 2014: Implications of different application sites on the bioavailability of a transdermal contraceptive patch containing ethinyl estradiol and gestodene: an open-label, randomized, crossover study International Journal of Clinical Pharmacology and Therapeutics 52(10): 856-866
Reid, R.L.; Fortier, M.P.; Smith, L.; Mirkin, S.; Grubb, G.S.; Constantine, G.D. 2010: Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada Contraception 82(6): 497-502
Gingnell, M.; Engman, J.; Frick, A.; Moby, L.; Wikström, J.; Fredrikson, M.; Sundström-Poromaa, I. 2013: Oral contraceptive use changes brain activity and mood in women with previous negative affect on the pill--a double-blinded, placebo-controlled randomized trial of a levonorgestrel-containing combined oral contraceptive Psychoneuroendocrinology 38(7): 1133-1144